KK Women’s and Children’s Hospital (KKH) has established the new Children’s Blood and Cancer Centre (CBCC) to advance research, education and complex care for blood and cancer disorders in babies and children.
KK Women’s and Children’s Hospital (KKH) has established the new Children’s Blood and Cancer Centre (CBCC) to advance research, education and complex care for blood and cancer disorders in babies and children.
Launched in February 2022, the CBCC is one of the most comprehensive paediatric blood and cancer centres in Southeast Asia, focusing on basic science and translational research in childhood cancers, and clinical research in paediatric blood and cancer disorders.
"Research is key in improving outcomes in childhood blood and cancer disorders. As these conditions are rare, with the majority of them having unknown causes, multi-centre and international collaborations are important to advance cures and improve our young patients’ health outcomes."
- Prof Leung Wing Hang,
Director, CBCC and Visiting Consultant,
Haematology/Oncology Service, KKH
MULTIDISCIPLINARY, INDIVIDUALISED CARE
“Cancers in children can be broadly classified as blood
cancers, brain tumours and solid tumours. Building
on decades of cancer research at KKH, the CBCC
will bring us a step closer towards enabling every
patient to receive holistic, individualised and targeted
treatment,” shares Dr Soh Shui Yen, Head and Senior
Consultant, Haematology/Oncology Service, KKH.
The CBCC is led by a multidisciplinary team of
paediatric oncology specialists in the fields of:
- Paediatric haematology/oncology
- Paediatric surgical oncology
- Neurosurgery
- Radiation oncology
- Pathology and molecular pathology
- Diagnostic and interventional imaging
- Nuclear medicine
- Nursing
- Allied health
CONDITIONS SEEN AT THE CBCC
The centre provides holistic care for paediatric
oncology patients diagnosed with:
- Various types of leukaemia and lymphoma
- Embryonal brain tumours
- High- and low-grade gliomas
- Neuroblastoma
- Childhood liver and renal tumours
- Bone tumours
- Soft tissue sarcomas
- Rare malignancies
GLOBAL RESEARCH INTEGRATION
The CBCC uses the latest treatment protocols of
international childhood tumour study groups such as
for liver and kidney tumours, and is the only participating
site in Southeast Asia to do so. It also provides
pathology and molecular pathology consultations for
challenging and rare childhood cancers in the region
THE BLOOD AND MARROW
TRANSPLANTATION AND CELLULAR
THERAPY PROGRAMME
Transplantation
Beyond clinical treatment, the CBCC houses the Blood
and Marrow Transplantation and Cellular Therapy
(BMTCT) programme, which has been providing
bone and marrow transplantation for children with
malignant and non-malignant conditions since 1998.
The availability of advanced donor graft manipulation
techniques and supportive care further increases
the potential for more eligible donors and cures
for patients.
Advanced therapies
Since 2020, the BMTCT programme offers chimeric
antigen receptor (CAR) T-cell therapy for patients
with relapsed refractory haematologic malignancies,
with two approved clinical trials recruiting eligible
patients. Rapid advances in the cellular therapy field
will enable CAR T-cell therapy to be a safer and more
cost-effective treatment, and benefit more patients
with different types of cancer.
HOLISTIC FOLLOW-UP AND CARE
The KKH Childhood Cancer Survivorship Programme
also provides holistic follow-up and care for childhood
cancer survivors, and collects longitudinal health data
to inform care and support.
Any patient with a history of childhood cancer or
cancer/transplant treatment during childhood can be
referred to the programme.
General practitioners can refer paediatric
patients to: |
Our Care Team
Director
Prof Leung Wing Hang
Visiting Consultant,
Haematology/Oncology Service
Manager
Ms Angeline Lim
Asst Manager,
Haematology/Oncology Service
Committee Chair
Dr Soh Shui Yen
Head & Senior Consultant,
Haematology/Oncology Service
Benign Haematology Lead
Clin Assoc Prof Joyce Lam
Senior Consultant,
Haematology/Oncology Service;
Deputy Head,
Department of Pathology and Laboratory Medicine
Malignant Haematology Lead
Dr Rajat Bhattacharyya
Senior Consultant,
Haematology/Oncology Service
Blood and Marrow Transplant and Cellular Therapy Lead
Dr Michaela Seng
Senior Consultant,
Haematology/Oncology Service
Brain and Solid Tumours Lead
Dr Amos Loh
Senior Consultant,
Department of Paediatric Surgery
Survivorship and Late Effects Lead
Clin Assoc Prof Tan Ah Moy
Senior Consultant,
Haematology/Oncology Service
Psychosocial, Preventive, Palliative and Supportive Care Leads
Clin Assoc Prof Chan Mei Yoke
Senior Consultant,
Haematology/Oncology Service
Dr Lois Teo
Head & Senior Principal Psychologist,
Psychology Service
Molecular and Histopathology Lead
Clin Assoc Prof Kenneth Chang
Head & Senior Consultant,
Department of Pathology and Laboratory Medicine
Data Science, Registry and Clinical Trial Management
Ms Germaine Liew
Senior Clinical Research Coordinator
GMP and Quality Management Lead
Dr Chu Pak Yan
Senior Principal Medical Lab Scientist,
Department of Pathology and Laboratory Medicine
